BioNTech SE (BNTX) – Strengthening capabilities through acquisitions

BNTX have strengthened their capabilities through the logistic acquisitions and collaborations. The
Medigene collaboration provides the opportunity to expand the spectrum of personalized T-cell therapies against various targets.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Segment Performance
– Key Developments

Peer Performance

– Summary
– Profitability
– Growth

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages : 27